BACKGROUND Heat-clearing and detoxifying drugs has protective effect on colorectal cancer(CRC).Given the complicated features of Traditional Chinese medicine formulas,network pharmacology is an effective approach for ...BACKGROUND Heat-clearing and detoxifying drugs has protective effect on colorectal cancer(CRC).Given the complicated features of Traditional Chinese medicine formulas,network pharmacology is an effective approach for studying the multiple interactions between drugs and diseases.AIM To systematically explore the anticancer mechanism of heat-clearing and detoxifying drug JC724.METHODS This study obtained the active compounds and their targets in JC724 from Traditional Chinese Medicine System Pharmacology Database.In addition,the CRC targets were obtained from Drugbank,TTD,DisGeNET and GeneCards databases.We performed transcriptome analysis of differentially expressed genes in CRC treated with JC724.Venn diagram was used to screen the JC724-CRC intersection targets as candidate targets.Core targets were selected by proteinprotein interaction network and herb ingredient-target-disease network analysis.The functional and pathway of core targets were analysed by enrichment analysis.RESULTS We found 174 active ingredients and 283 compound targets from JC724.940 CRC-related targets were reserved from the four databases and 304 CRC differentially expressed genes were obtained by transcriptome analysis.We constructed the network and found that the five core ingredients were quercetin,βBeta sitosterol,wogonin,kaempferol and baicalein.The core JC724-CRC targets were CYP1A1,HMOX1,CXCL8,NQO1 and FOSL1.JC724 acts on multiple signaling pathways associated with CRC,including the Nrf2 signaling pathway,oxidative stress,and the IL-17 signaling pathway.CONCLUSION In this study,we systematically analyzed the active ingredients,core targets and main mechanisms of JC724 in the treatment of CRC.This study could bring a new perspective to the heat-clearing and detoxifying therapy of CRC.展开更多
目的观察解毒活血配伍方药对载脂蛋白E基因敲除[apolipoprotein E gene knock-out,ApoE(-/-)mice]小鼠血清超敏C反应蛋白(hs-CRP)的影响。方法13周龄110只ApoE(-/-)小鼠分为高脂饲料组(98只,给予高脂饲料),普通饲料组(12只,给予普通饲...目的观察解毒活血配伍方药对载脂蛋白E基因敲除[apolipoprotein E gene knock-out,ApoE(-/-)mice]小鼠血清超敏C反应蛋白(hs-CRP)的影响。方法13周龄110只ApoE(-/-)小鼠分为高脂饲料组(98只,给予高脂饲料),普通饲料组(12只,给予普通饲料),同时设13周龄C57BL/6J小鼠作为正常对照组(12只,给予普通饲料)。19周后随机抽取高脂饲料ApoE(-/-)小鼠2只确认易损斑块形成后,剩余96只随机分为8组(模型组、解毒组、活血组、解毒活血配伍高、中、低剂量组、洛伐他汀组和血脂康组),每组12只。造模成功后每天给予药物干预,解毒组予虎杖提取物26·6mg/kg;活血组予芎芍胶囊110mg/kg;配伍高剂量组予虎杖提取物53·2mg/kg,芎芍胶囊220mg/kg;配伍中剂量组给予虎杖提取物26·6mg/kg,芎芍胶囊110mg/kg;配伍低剂量组给予虎杖提取物13·3mg/kg,芎芍胶囊55mg/kg;洛伐他汀组给予洛伐他汀3·3mg/kg;血脂康组给予血脂康0·2g/kg;以上药物根据剂量蒸馏水溶解,混匀后灌胃,每次0·4mL。模型组、普通饲料组、C57BL/6J小鼠对照组均灌服生理盐水0·4mL。用药17周后,下腔静脉取血,全自动酶标仪检测血清hs-CRP浓度。结果模型组血清hs-CRP水平显著高于正常对照组和普饲组(P<0·05,P<0·01);各给药组中,洛伐他汀组、解毒组和配伍高剂量组hs-CRP水平下降,与模型组比较,差异有统计学意义(P<0·01);配伍高剂量组hs-CRP水平低于洛伐他汀组、血脂康组、单纯解毒或活血组及配伍中、低剂量组;解毒组hs-CRP水平低于活血组(P<0·01)。结论解毒活血配伍方药可降低ApoE(-/-)小鼠血清hs-CRP水平。展开更多
基金Supported by The National Natural Science Foundation of China,No.82074061Beijing Natural Science Foundation Proposed Program,No.7202076.
文摘BACKGROUND Heat-clearing and detoxifying drugs has protective effect on colorectal cancer(CRC).Given the complicated features of Traditional Chinese medicine formulas,network pharmacology is an effective approach for studying the multiple interactions between drugs and diseases.AIM To systematically explore the anticancer mechanism of heat-clearing and detoxifying drug JC724.METHODS This study obtained the active compounds and their targets in JC724 from Traditional Chinese Medicine System Pharmacology Database.In addition,the CRC targets were obtained from Drugbank,TTD,DisGeNET and GeneCards databases.We performed transcriptome analysis of differentially expressed genes in CRC treated with JC724.Venn diagram was used to screen the JC724-CRC intersection targets as candidate targets.Core targets were selected by proteinprotein interaction network and herb ingredient-target-disease network analysis.The functional and pathway of core targets were analysed by enrichment analysis.RESULTS We found 174 active ingredients and 283 compound targets from JC724.940 CRC-related targets were reserved from the four databases and 304 CRC differentially expressed genes were obtained by transcriptome analysis.We constructed the network and found that the five core ingredients were quercetin,βBeta sitosterol,wogonin,kaempferol and baicalein.The core JC724-CRC targets were CYP1A1,HMOX1,CXCL8,NQO1 and FOSL1.JC724 acts on multiple signaling pathways associated with CRC,including the Nrf2 signaling pathway,oxidative stress,and the IL-17 signaling pathway.CONCLUSION In this study,we systematically analyzed the active ingredients,core targets and main mechanisms of JC724 in the treatment of CRC.This study could bring a new perspective to the heat-clearing and detoxifying therapy of CRC.
文摘目的观察解毒活血配伍方药对载脂蛋白E基因敲除[apolipoprotein E gene knock-out,ApoE(-/-)mice]小鼠血清超敏C反应蛋白(hs-CRP)的影响。方法13周龄110只ApoE(-/-)小鼠分为高脂饲料组(98只,给予高脂饲料),普通饲料组(12只,给予普通饲料),同时设13周龄C57BL/6J小鼠作为正常对照组(12只,给予普通饲料)。19周后随机抽取高脂饲料ApoE(-/-)小鼠2只确认易损斑块形成后,剩余96只随机分为8组(模型组、解毒组、活血组、解毒活血配伍高、中、低剂量组、洛伐他汀组和血脂康组),每组12只。造模成功后每天给予药物干预,解毒组予虎杖提取物26·6mg/kg;活血组予芎芍胶囊110mg/kg;配伍高剂量组予虎杖提取物53·2mg/kg,芎芍胶囊220mg/kg;配伍中剂量组给予虎杖提取物26·6mg/kg,芎芍胶囊110mg/kg;配伍低剂量组给予虎杖提取物13·3mg/kg,芎芍胶囊55mg/kg;洛伐他汀组给予洛伐他汀3·3mg/kg;血脂康组给予血脂康0·2g/kg;以上药物根据剂量蒸馏水溶解,混匀后灌胃,每次0·4mL。模型组、普通饲料组、C57BL/6J小鼠对照组均灌服生理盐水0·4mL。用药17周后,下腔静脉取血,全自动酶标仪检测血清hs-CRP浓度。结果模型组血清hs-CRP水平显著高于正常对照组和普饲组(P<0·05,P<0·01);各给药组中,洛伐他汀组、解毒组和配伍高剂量组hs-CRP水平下降,与模型组比较,差异有统计学意义(P<0·01);配伍高剂量组hs-CRP水平低于洛伐他汀组、血脂康组、单纯解毒或活血组及配伍中、低剂量组;解毒组hs-CRP水平低于活血组(P<0·01)。结论解毒活血配伍方药可降低ApoE(-/-)小鼠血清hs-CRP水平。